BROWSE ALL ARTICLES BY TOPIC
EXCLUSIVE ONLINE ARTICLES
Listing articles 1 to 10 of 98
Squishy gel could include a chemical compound capable of helping repair, restore or regenerate cartilage in a joint.
Data suggest the 'foreign' antigen triggering the autoimmune response in scleroderma patients is actually a tumor antigen.
Features: TNF Inhibitors & RA
Benefits from biologic agents may extend beyond protection from progressive joint destruction and even enhance long-term survival.
“The ICD-10 testing week has been created to generate awareness and interest, and to instill confidence in the provider community that CMS and the MACs are ready and prepared for the ICD-10 implementation,” CMS noted.
An expert in psoriatic arthritis says a soon-to-be widely available new drug may be a boon to rheumatologists—if it’s not too costly.
Features: Human RNAi Therapy Jumps Hurdle
A new proof-of-concept human study brings RNA interference therapy one step closer to market. (published March 3, 2014)
A new study suggests that intestinal expansion of Prevotella copri may be associated with the pathogenesis of RA (published Feb. 20, 2014)
GlaxoSmithKline has decided to stop paying physicians to promote its products and to cease tying sales-representative compensation to the number of prescriptions physicians write. (posted Feb. 14)
Women with gout are more likely to have contraindications to nonsteroidal antiinflammatory drugs and are less likely to receive urate-lowering drugs than men with the disease. (posted Feb. 5)
New research clarifies the role of fibroblasts in chronic lung disease. (posted Jan. 21)